Pfizer Strikes a Deal With the Medicines Patent Pool for Generic Versions of Its COVID-19 Pill in Poor Countries

“The license between Pfizer and the Medicines Patent Pool is disappointingly limited to only 95 countries with just 53% of the world’s population, or 4.1 billion people,” Professor Brook Baker tell STAT.